Lecture 32 - Vaccination II Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Compare **empirical **and rational approaches to vaccine development

List vaccines that have been developed in these ways

A

Empirical

  • “Trial & error” methodologies
  • Based on knowledged gained by direct observation of an experiment
  • Many traditional vaccines

Rational

  • Based on logic and deduction
  • Using data from experiements to guide and inform
  • HPV (Gardasil; VLP), HBsAg subunit vaccine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the imporance of Dendritic cells in vaccine design?

A

A good vaccine strategy needs to license / activate DCs

  • DCs play a crucial role in shaping the immune response
    • Become activated by sensing ‘Danger’
    • Intracellular transduction pathway
    • Transcription of genes
  • Activation of DCs
    • ​Recognise PAMPs / DAMPs through PRRs
      • TLRs
      • C-type lectin receptors
      • RLRs
      • NLRs
  • Release of pro-inflammatory cytokines that regulate:
    • ​Adaptive immune response generation
    • Proliferation
    • Inflammation
    • Apoptosis
    • Immune regulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is therapeutic vaccination?

A

Vaccination after establishment of infection / disease

eg. Improvement of T cell immunity to tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How has basic research in the field of immunology impacted modern therapeutics?

A
  • Understanding mechanisms of immune induction
    • ​Role of innate immunity
    • Requirements of lymphocyte activation
    • Induction of immune memory
  • Understanding cell mediated immunity
    • ​Clearance of intracellular infection
    • Recognition of tumour Ags by CD8 T cells
  • Therapeutic vaccination
    • ​eg in tumour immunotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What can techniques such as ELISA & MHC-peptide tetramer staining tell us?

A
  • Can tell us about the responses elicited by vaccines
  • Whether or not the vaccine is effective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can vaccine efficacy be measured?

A
  • Ab responses
    • ​ELISA
      • ​Titre (magnitude of response)
      • Isotype
        • IgG: memory formation
        • IgA: mucosal immunity
    • Surface plasmon resonance technology
      • ​Binding affinity
  • Cell mediated responses
    • ​Intracellular cytokine staining assays
    • pMHC tetramers
      • ​Detection of specific T cells (ie specific for vaccine Ag)
      • Look at the proliferation of these specific T cells
    • Dye-base in vivo and in vitro killing assays
      • Ability of T cells to kill infected cells
    • Bead arrays & ELISA
      • ​Overall cytokine levels in blood & tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do molecular biology techniques allow in vaccine development?

A
  • DNA sequencing
    • ​Sequence pathogen genomes
    • Identify important genes for virulence
  • Determine antigenic determinants of pathogens
  • Mutation of pathogen
    • ​Rational attenuation for production of vaccine strains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which things must be considered for rational design of a vaccine?

A
  • Type of vaccine
    • Attenuated, inactivated, subunit, DNA?
    • eg might need to use subunit vaccine, as the pathogen cannot be attenuated
  • Type of response required
    • ​Cell mediated or humoral?
    • Based on the type of infection caused by the pathogen (intra- or extracellular)
  • Target
    • ​The pathogen itself?
    • Product? (toxin, secretory factor)
  • Safety profile & risk
    • ​Toxicity, AEs, tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How were pathogens attenuated in the past?

A
  • Passage of the pathogen through cells or other organisms
  • The pathogen must adapt to this new environment:
    • Different selective pressures
    • Mutation of the pathogen
  • In so doing, the pathogen loses its ability to infect humans
  • Disadvantages:
    • Do not know which mutations have occurred
    • If there aren’t enough mutations, pathogen can revert to virulence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the process of rational attenuation of pathogens

A

Example approach by reverse genetics:

  1. ​Clone genome of pathogen
  2. Identify genes:
    • ​Virulence
    • Replication
    • Antigenic proteins
  3. Mutate or delete virulence gene, whilst leaving others in tact
    • Mutate by selective mutagenesis
    • ​Deletion is safer: can’t revert to virulence
      • But can the virus still replicate?
  4. Pathogen can no longer cause harm, but can infect and induce an immune response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe vector vaccines

Which vectors are used?

What are the advantages and disadvantages of this method?

A

Bacteria or viruses

  • Approach
    • ​Attenuated pathogen
    • Engineered to express Ags from another organism
  • Example vehicles:
    • ​Adenoviruses
    • Attenuated Salmonella
    • Poxviruses
      • Vaccinia
      • Canarypox
    • Genomes are quite large, and thus can accommodate additional genes without compromise
  • Advantages:
    • ​Mimics natural infection
    • High levels of expressed Ag
    • Mucosal administration
    • Elicits both T & B cell responses
    • Antigens are properly folded
      • ​Important for conformational Ags
      • Maintain proper 2° and 3° structure
  • Disadvantages
    • ​Can be dangerous in the immunocompromised
    • The vector can be the target of an immune response with repeated use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List the various types of subunit vaccines

A
  • Recombinant proteins
  • Peptide vaccines
  • VLPs: virus-like particles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are recombinant proteins made?

What are the disadvantages of these vaccines?

A
  • ​Generation:
    • Using recombinant DNA technology
      • ​Plasmid encoding the Ag is introduced into an organism
      • Yeast
      • Bacteria
      • Insect cells
    • Organism produces the Ag
  • Disadvantages
    • ​Low immunogenicity
    • Requires adjuvants
    • Need to identify the protective Ag
    • Can be difficult to manufacture (purification of recomb. proteins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the features of peptide vaccines

How are they manufactured?

What are the advantages and disadvantages?

A
  • Composition:
    • Peptide represents epitope of:
      • B cell
      • CD8 T cell
      • ​CD4 T cell
    • Adjuvant
    • ​TLR agonists
    • ISCOMs
  • Manufacture
    • ​Synthetically generated
  • Advantages
    • ​Very safe
    • Very defined composition
    • No risk of reversion
  • Disadvantages
    • Not very immunogenic
    • ​B cell determinants are often not native-like
      • Often linear sequences: thus limited to immune responses against non-conformational antigens
    • T cell determinants are MHC restricted
      • eg only HLA-A2
      • The vaccine would thus only work in individuals with this haplotype
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are ISCOMs?

A

Immune Stimulating COMplexes

  • Used in peptide vaccines
  • Like an adjuvant
  • Helps the take up of the peptides by DCs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are **polytope **vaccines?

What are the advantages and disadvantages?

A

Solves problem of MHC restriction of peptide vaccines

  • Genetic engineering to generate a peptide that has multiple epitopes
  • These epitopes are:
    • ​Different epitopes of the same organism
      • Bind different HLA molecules
    • Epitopes from different organisms
  • Advantages​
    • ​Provides a range of epitopes from a single organism that are presented by different MHC molecules
  • Disadvantages
    • ​Appropriate processing of T cell epitopes
    • Competition for MHC binding
      • One epitope may be preferentially presented over the others
    • Some T cell responses can predominate
17
Q

Describe the features of VLP subunit vaccines

A
  • MOA:
    • Capsid or envelope of some viruses self assemble in the absence of the genome
    • VLP binds and enters cell
    • Capsid subunits induce immune response
      • ​Both cellular and humoral
  • eg. Gardasil HPV vaccine
18
Q

Describe the Gardasil vaccine

A
  • VLP subunit vaccine
  • **L1 **(major capsid protein) of HPV self-assembles
    • ​L1 of HPV types 6, 11 & 18
19
Q

What is Pam2Cys?

Describe its use in vaccines

A
  • PAMP (lipopeptide) recognised by TLR2
  • Stimulates the formation of TLR2/6 heterodimers
  • Triggers formatino of an endosome
  • (Whatever is bound to Pam2Cys will be taken up into the cell)
  • Engineered onto subunit vaccines to increase delivery to DCs
  • DC captures whatever is bound to Pam2Cys, intiating a signalling cascade
    • ​MyD88
    • Activation of TFs
    • Transcription of genes
    • Activation of DCs
      • ​Pro-inflammatory molecule expression
      • Co-stimulatory molecule expression
20
Q

What is TLR2?

List the important features

What is its role in vaccines?

A
  • Features:
    • PRR expressed on many immune cells
      • ​DCs, macrophages, PMNs, monocytes, lymphocytes
    • Recognises bacterial-derived lipopeptides
      • eg. Pam2Cys
    • Present in the endosome
  • Role in vaccines:
    • ​Subunit vaccines can be made immunogenic if they express Pam2Cys
    • Pam2Cys ligates TLR2
    • Transduction pathway leading to the activation of NFKB
    • NFKB turns on pro-inflammatory & activating genes in DC
    • Activation of DCs
      • ​Expression of co-stimulatory molecules, migration to draining LNs
    • Induction of a robust immune response
21
Q

Describe DNA vaccines:

  • Contents
  • Generation
  • Mechanism
A
  • Contents:
    • Plasmid encoding:
      • Eukaryotic promoter
      • Gene for pathogen Ag
      • Poly-A tail
      • Bacterial origin or replication (Ori)
        • Allows replication of the plasmid in bacteria
      • Selective marker for growth (antibiotic resistance)
      • Unmethylated CpG motifs
    • Saline solution
  • Generation
    • ​Generated in bacteria
    • Replicated in bacteria
      • ​Hence requirement of Ori
    • Harvested
  • Mechanism
    • ​Injection of plasmid into muscle / coating on gold beads and ‘gene gun’ administration
    • Transfection (DNA enters host cells)
    • DNA moves to nucleus
    • Transcription of DNA into mRNA by RNApol
    • mRNA translated into protein in the cytosol
      • Transfected cell processes and presents protein, or
      • Release of protein, capture and presentation by APC
22
Q

Describe how DNA vaccines can be administered

A
  1. Injection into muscle
  2. Gene gun
    • ​​Plasmid coated onto gold beads
    • Air highly pressurised → penetrates skin
    • Plasmid taken up by skin DCs
23
Q

What are the advantages and disadvantages of DNA vaccines?

A
  • Advantages
    • ​Cheap to generate DNA
    • Easy to manufacture
    • Long lasting response
    • Can deliver a combination of plasmids
    • ​Various Ags
      • Immunomodulatory molecules
      • Unmethylated CpG motifs: TLR9 agonist
  • Disadvantages
    • ​Oncogene activation
      • Can’t control where the DNA will insert
    • Low uptake into cells
    • Hypersensitivity against Ag or DNA
    • Limited administration
      • Only injection into muscle / gene gun
    • Efficacy in small animal models doesn’t translate
    • Large doses required
24
Q

What is the main advantage of administration of DNA vaccines by gene guns?

A

Delivers DNA efficiently to skin DCs

25
Q

Describe **immunomodulation **of DNA vaccines

A

Used to shape the immune response

  • ​Plasmids encoding pro-inflammatory cytokines
    • ​GM-CSF
    • IFN-gamma
    • IL-12
    • IL-15
  • Co-administration of mAb/cytokine
    • ​mAb: anti-CTLA4 (Ipilimumab)
    • Enhances the immune response
26
Q

How can DNA vaccines be improved?

A
  1. Immunomodulation
    • Immune response is enhanced against antigen
    • Co-administration of Ipilimumab / cytokine
    • Plasmid encoded cytokines
  2. Viral / bacterial vectors
    • ​Faster replication and expression of antigen
27
Q

What is one significant benefit of subunit vaccines over whole pathogen vaccines?

A
  • Whole pathogen vaccines pose a risk to the individual; could infect & cause harm
  • Subunits can not cause harm
28
Q

Why is use of adjuvants a problem?

A
  • There are very many adjuvants available that are approved for use in humans
  • Alum is one of the only ones
    • Very good induction of Ab responses
    • Poor induction of cell-mediated responses
29
Q

What is systems biology?

List some of the techniques that are used

How can it be used in vaccine design?

A
  • Systems biology:
    • “Computational and mathematical modelling of complex biological systems”
    • Use of:
      • Gene array chips
        • ​See which genes are ON or OFF
        • Snapshot of the genetic landscape of a cell or tissue
      • NextGen Sequencing
        • ​Sequence entire genome of pathogen or host
      • RNA-seq
        • ​Sequencing of RNA
        • Look at the mRNA that is produced
        • Indicates which genes are being utilised
      • Bioformatics tools
        • ​Supercomputers
        • Need to be able to interpret all this information
          • ​Pathway analysis
          • Differential expression of genes
          • Signalling pathways
  • In vaccine design:
    • Really powerful tool
    • Comprises a range of techniques to help us understand the effect of a vaccine on the body as a whole:
      • ​Genomic level
      • Phenotypic level
      • Mechanism of protection
    • **eg **Yellow fever vaccine
30
Q

Describe how systems biology was used to investigate the Yellow Fever vaccine

A

Yellow fever vaccine:

  • ​Live-attenuated vaccine
  • Been around for 65 years
  • ‘Travel vaccine’
  • Very effective vaccine
    • ​Hence, also used as a vaccine delivery vector
  • Molecular mechanisms of inducing immunity are unknown

Querec et al. 2009 trial

  • Aim: Identification of the molecular signatures evoked by the vaccine
  • Design:
    • ​Administration of the vaccine to naïve individuals
    • Two separate trials
    • At two time points, bleed the individuals to acquire peripheral blood lymphocytes
    • Perform gene array and **transcription profiling **on these samples
    • Analysed which genes were switched on and off
    • Indentify the genes that were commonly induced after vaccination
    • These genes were then associated with a specific type of immunity
      • ​eg anti-viral / parasitic response
        • Gene network analysis:
          • Look at the overal impact of the genes
  • Conclusions
    • ​Genes induced after vaccination:
      • Help regulate the innate immune response
      • have IRF7/9 binding sites
        • ​ie Interferon binding sites